Fecal Calprotectin Evaluation in Patients with Ulcerative Colitis
Authors:
- 14 January 2015
- journal article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 60 (4) , 1109-1110
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel diseaseClinical and Experimental Gastroenterology, 2014
- Fecal Calprotectin and the Clinical Activity Index Are Both Useful to Monitor Medical Treatment in Patients with Ulcerative ColitisDigestive Diseases and Sciences, 2014
- The intra-individual variability of faecal calprotectin: A prospective study in patients with active ulcerative colitisJournal of Crohn's and Colitis, 2014
- Fecal calprotectin levels in patients with cystic fibrosisThe Turkish Journal of Pediatrics, 2014
- Probiotics on fecal calprotectin of cystic fibrosis. ReplyThe Turkish Journal of Pediatrics, 2014
- Plasma S100A8/A9 Correlates With Blood Neutrophil Counts, Traditional Risk Factors, and Cardiovascular Disease in Middle-Aged Healthy IndividualsArteriosclerosis, Thrombosis, and Vascular Biology, 2014
- Stability of the Maternal Gut Microbiota During Late Pregnancy and Early LactationCurrent Microbiology, 2013
- Statins are associated with reduced use of steroids in inflammatory bowel disease: A retrospective cohort study*Inflammatory Bowel Diseases, 2012
- Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double‐blind placebo‐controlled studyAlimentary Pharmacology & Therapeutics, 2010
- Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical IndicesAmerican Journal of Gastroenterology, 2008